menu
    • menu

    Company profile for Atreca

    NEW Drugs in Dev: 6
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a biopharmaceutical company developing novel therapeutics based on a deep understanding of the human immune response. We focus in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies, including those in our lead programs in oncology. The proprietary Atreca Discovery Platform h...
    We are a biopharmaceutical company developing novel therapeutics based on a deep understanding of the human immune response. We focus in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies, including those in our lead programs in oncology. The proprietary Atreca Discovery Platform has been validated repeatedly via partnerships with major pharmaceutical companies, non-profit foundations, academic institutions, and governmental entities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AtrecaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    450 E Jamie Court South San Francisco, CA 94080
    Telephone
    Telephone
    +1.​650.595.2595
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atreca.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atreca-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets
    Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets

    26 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/26/2801085/0/en/Atreca-Announces-Asset-Purchase-Agreement-for-Sale-of-Antibody-Related-Assets-and-Materials-to-Immunome.html

    GLOBENEWSWIRE
    26 Dec 2023
    Share Share
    Atreca cuts head count by 40% for 2nd time in 3 months
    Atreca cuts head count by 40% for 2nd time in 3 months

    15 Nov 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/atreca-facing-q1-funding-cliff-edge-cuts-headcount-40-second-time-3-months

    Nick Paul Taylor FIERCE BIOTECH
    15 Nov 2023
    Share Share
    Atreca Reports Third Quarter 2023 Financial Results
    Atreca Reports Third Quarter 2023 Financial Results

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2780574/0/en/Atreca-Reports-Third-Quarter-2023-Financial-Results-and-Announces-Further-Reorganization-to-Support-Exploration-of-Strategic-Alternatives.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    Atreca Announces Agreement to Terminate Lease
    Atreca Announces Agreement to Terminate Lease

    21 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/21/2747233/0/en/Atreca-Announces-Agreement-to-Terminate-Lease-and-Departure-of-Chief-Financial-Officer-Herb-Cross.html

    GLOBENEWSWIRE
    21 Sep 2023
    Share Share
    Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
    Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs

    11 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/atreca-former-big-pharma-darling-axes-lead-drug-40-staff-last-ditch-pivot-adcs

    Nick Paul Taylor FIERCE BIOTECH
    11 Aug 2023
    Share Share
    Atreca holds off development on its only clinical program, cuts headcount by 40%
    Atreca holds off development on its only clinical program, cuts headcount by 40%

    11 Aug 2023

    // Reynald Castañeda ENDPTS

    https://endpts.com/atreca-suspends-solid-tumor-antibody-development-cuts-headcount-by-40/

    Reynald Castañeda ENDPTS
    11 Aug 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search